Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (15)
  • News item (8)
  • Activity (1)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) March 2021 (12)
  • (-) November 2018 (14)
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (9)
  • December 2025 (21)
  • November 2025 (16)
  • October 2025 (11)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • June 2025 (8)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (20)
  • December 2024 (13)
  • November 2024 (7)
  • October 2024 (10)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • March 2024 (10)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (19)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (11)
  • August 2022 (10)
  • July 2022 (18)
  • June 2022 (18)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • February 2022 (7)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • May 2021 (15)
  • April 2021 (15)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (2)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (4)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • International (3)
  • Chromium (VI) and CARC (1)
  • Circular economy (1)
  • Contact (1)
  • Sustainability (1)
  • Tuberculosis (1)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (1)

26 search results

You searched for these word(s): risk assessment
  • Chemical Safety Assessment under REACH, 3-6 July 2018

    https://www.rivm.nl/en/agenda/chemical-safety-assessment-under-reach-3-6-july-2018

    … training provides a full introduction in chemical safety assessment as required in the EU legislation REACH … is organized in close collaboration with Institute for Risk Assessment Sciences (IRAS) Utrecht University. … assessment (day 2 and 3), exposure assessment (day 3), and risk characterization (day 3). During teh course we briefly …

    Publication date: 11-02-2018
  • WP 5: Advancement of Regulatory Risk Assessment and Testing

    https://www.rivm.nl/en/international-projects/nanoreg/work-package/wp-5-advancement-of-regulatory-risk-assessment-and-testing

    …   SOP 02 Real-time label-free impedance-based nanotoxicity assessment       SOP 03 SOP for High Throughput Cell … cell assay for cytokine production D5.08 Decision tree for risk assessment of MNMs 5 RIVM FlowChart NANoREG nanospecific risk assessment strategy D5.09 Summary report WP5     If not …

    Publication date: 11-22-2018
  • Medical high-risk groups invited for vaccination starting this week

    https://www.rivm.nl/en/news/medical-high-risk-groups-invited-for-vaccination-starting-this-week

    … Five groups of patients with specific medical risks will receive an invitation for COVID-19 vaccination … will also be invited to get vaccinated. They have a higher risk of severe illness or death due to COVID-19. The … Medical high-risk groups invited for vaccination starting this week …

    Publication date: 03-17-2021
  • NESTI-NEDI

    https://www.rivm.nl/en/chemkap/nesti-nedi

    … Dutch dietary risk assessment models for pesticide authorisation purposes … intake is compared to a toxicological reference value. This risk assessment is a default part of the pesticide authorisation …

    Publication date: 11-06-2018
  • New WHO protocol for integrated One Health surveillance of antibiotic resistance: the Tricycle protocol

    https://www.rivm.nl/en/news/new-who-protocol-for-integrated-one-health-surveillance-of-antibiotic-resistance-tricycle

    … comparable country data. RIVM's WHO Collaborating Centre Risk Assessment of Pathogens in Food and Water  has actively …

    Publication date: 03-03-2021
  • Newsletter on COVID-19 vaccination issue 8 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/8

    … Vaccination prioritisation for high-risk groups … greenlighted earlier vaccination of people at very serious risk of severe illness or death due to COVID-19 infection. A vaccination route has now been set in motion for two risk groups: people with Down’s Syndrome and people with …

    Publication date: 03-01-2021
  • Method for safe and sustainable recycling of waste

    https://www.rivm.nl/en/news/method-for-safe-and-sustainable-recycling-of-waste

    … The method developed by RIVM to assess whether waste treatment is sufficiently safe and … for a safe and more circular economy. With the method, an assessment framework, the safety as well as the contribution to sustainability can be assessed when processing  residual flows  into new materials …

    Publication date: 03-23-2021
  • Fact sheets WP4-WP6

    https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoreg/factsheets/fact-sheets-wp4-wp6

    … methodology to evaluate NM toxicity D5.08 Decision tree for risk assessment of MNMs   D6.01 Proposal to monitor innovations … and their applications D6.02 Inventory of safety assessment issues and new approaches to research and …

    Publication date: 11-20-2018
  • Vaccination with AstraZeneca vaccine temporarily on hold

    https://www.rivm.nl/en/news/vaccination-with-astrazeneca-vaccine-temporarily-on-hold

    … and Denmark at this time. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently conducting further …

    Publication date: 03-15-2021
  • NANoREG D5.08 FS Flow chart for risk assessment of nanomaterials

    https://www.rivm.nl/en/documenten/nanoreg-d508-fs-flow-chart-for-risk-assessment-of-nanomaterials

    … NANoREG D5.08 FS Flow chart for risk assessment of nanomaterials … NANoREG D5.08 FS Flow chart for risk assessment of nanomaterials …

    Publication date: 11-22-2018
  • Fact sheets WP1-WP3

    https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoreg/factsheets/fact-sheets-wp1-wp3

    … D1.08 A summary on the deliverables related to the VCCSs Assessment of value chain case studies Case studies of the … dispersion and transfer D3.09 Data on the effectiveness of risk management measures …

    Publication date: 11-20-2018
  • WP 6: Keeping pace with innovation

    https://www.rivm.nl/en/international-projects/nanoreg/work-package/wp-6-keeping-pace-with-innovation

    … and their applications 41   D6.02 Inventory of safety assessment issues and new approaches to research and …

    Publication date: 11-22-2018
  • WP 2: Synthesis, supplying and characterisation

    https://www.rivm.nl/en/international-projects/nanoreg/work-package/wp-2-Synthesis-supplying-and-characterisation

    … content in MNMs by thermogravimetric analysis (TGA) SOP for assessment of the contents of water, organic compounds, and …

    Publication date: 11-20-2018
  • NANoREG D3.09 FS Effectiveness of risk management measures

    https://www.rivm.nl/en/documenten/nanoreg-d309-fs-effectiveness-of-risk-management-measures

    … NANoREG D3.09 FS Effectiveness of risk management measures … NANoREG D3.09 FS Effectiveness of risk management measures …

    Publication date: 11-20-2018
  • Questions and Answers about vaccination with AstraZeneca

    https://www.rivm.nl/en/covid-19-vaccination/vaccines/astrazeneca

    … for people aged 60 and over (born in 1960 or before). The risk of serious consequences from COVID-19 is much higher than the risk of this serious but rare combination of blood clots and … COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low …

    Publication date: 03-22-2021
  • LICARA NanoScan

    https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoregii/introduction-sia-toolbox/licara-nanoscan

    … which enables the evaluation of the benefits and risks qualitatively with low and manageable efforts, over … life time. It further allows a comparison with the risks and benefits of the conventional (non-nano) poducts. …

    Publication date: 11-20-2018
  • RIVM advises caution when using herbal preparations containing St John's wort

    https://www.rivm.nl/en/news/rivm-advises-caution-when-using-herbal-preparations-containing-st-johns-wort

    … not to combine herbal preparations with medicines. Risks of using St John's wort without medicines Even without … of herbal preparations with St John's wort may pose health risks. For example, sunburn can occur if people sit in the …

    Publication date: 03-16-2021
  • Newsletter on COVID-19 vaccination issue 10 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/10

    … thrombocytopaenia with indications of higher bleeding risk such as petechiae, purpura or spontaneous haematomas. …

    Publication date: 03-16-2021
  • Coordinated Vulnerability Disclosure

    https://www.rivm.nl/en/contact/coordinated-vulnerability-disclosure

    … lead to additional damage and cause unnecessary security risks. Exploiting a vulnerability more than is strictly …

    Publication date: 11-21-2018
  • Experimental data on exposure

    https://www.rivm.nl/en/about-rivm/mission-and-strategy/international-affairs/international-projects/nanoreg/experimental-data-on-exposure

    … measurement instruments, tools and methods Nano-Specific Risk Management Measures Library If not indicated otherwise, …

    Publication date: 11-22-2018

Pagination

  • Current page 1
  • Page 2
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon